William Abraham
- Type
- Physician · Allopathic & Osteopathic Physicians / Internal Medicine / Advanced Heart Failure and Transplant Cardiology
- Where
- Powell, OH
- NPI
- 1093755944
- Received
- $838,951 in 103 records, 2019 to 2025 ($802,081 general, $36,869 research)
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 19 | $104,970 |
| 2025 | Ownership or investment interest | 1 | $0 |
| 2024 | General payment | 19 | $134,750 |
| 2024 | Research payment | 3 | $19,000 |
| 2023 | General payment | 16 | $127,731 |
| 2023 | Research payment | 5 | $16,082 |
| 2022 | General payment | 8 | $109,987 |
| 2021 | General payment | 8 | $72,439 |
| 2020 | General payment | 11 | $101,582 |
| 2019 | General payment | 12 | $150,618 |
| 2019 | Research payment | 1 | $1,787 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| ZOLL Respicardia, Inc. | 34 | $348,550 | 2019–2025 |
| Sensible Medical Innovations Ltd | 6 | $249,000 | 2019–2025 |
| scPharmaceuticals Inc. | 14 | $133,127 | 2023–2025 |
| CVRx, Inc. | 14 | $41,008 | 2019–2025 |
| Impulse Dynamics (USA) Inc. | 12 | $28,000 | 2020–2024 |
| Boehringer Ingelheim France S.A.S. | 1 | $20,013 | 2020 |
| Abbott Laboratories | 9 | $9,353 | 2019–2024 |
| Boehringer Ingelheim International GmbH | 8 | $4,318 | 2019–2021 |
| Novartis Pharmaceuticals Corporation | 1 | $3,960 | 2019 |
| Edwards Lifesciences Corporation | 2 | $1,576 | 2022 |
| Kestra Medical Technology Services, Inc. | 1 | $28 | 2024 |
| Boston Scientific Corporation | 1 | $14 | 2025 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Consulting Fee | 45 | $606,192 |
| Honoraria | 16 | $141,250 |
| Research payment | 9 | $36,869 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a v | 10 | $24,018 |
| Compensation for serving as faculty or as a speaker for a medical education program | 3 | $21,900 |
| Travel and Lodging | 6 | $4,222 |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing | 1 | $3,500 |
| Food and Beverage | 12 | $997 |
| Ownership or investment interest | 1 | $0 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-12-18 | Boston Scientific Corporation | $14 | Food and Beverage | In-kind items and services | BodyGuardian Device, CDS - BG Mini Plus_RM | 2025 | |
| 2025-12-01 | ZOLL Respicardia, Inc. | $1,950 | Consulting Fee | Cash or cash equivalent | remede System Device, Respiratory | 2025 | |
| 2025-11-04 | ZOLL Respicardia, Inc. | $77 | Food and Beverage | Cash or cash equivalent | remede System Device, Respiratory | 2025 | |
| 2025-11-03 | Sensible Medical Innovations Ltd | $36,000 | Consulting Fee (4 payments) | Cash or cash equivalent | ReDS system Device, Heart failure | 2025 | |
| 2025-11-01 | ZOLL Respicardia, Inc. | $4,550 | Consulting Fee | Cash or cash equivalent | remede System Device, Respiratory | 2025 | |
| 2025-11-01 | ZOLL Respicardia, Inc. | $1,950 | Consulting Fee | Cash or cash equivalent | remede System Device, Respiratory | 2025 | |
| 2025-10-22 | CVRx, Inc. | $51 | Food and Beverage | Cash or cash equivalent | Barostim Neo System Device, Heart Failure and Hypertension | 2025 | |
| 2025-10-17 | scPharmaceuticals Inc. | $916 | Travel and Lodging | Cash or cash equivalent | FUROSCIX Drug, Cardiology | 2025 | |
| 2025-09-18 | scPharmaceuticals Inc. | $13,750 | Honoraria | Cash or cash equivalent | FUROSCIX Drug, Cardiology | 2025 | |
| 2025-09-01 | ZOLL Respicardia, Inc. | $2,600 | Consulting Fee | Cash or cash equivalent | remede System Device, Respiratory | 2025 | |
| 2025-08-01 | ZOLL Respicardia, Inc. | $1,300 | Consulting Fee | Cash or cash equivalent | remede System Device, Respiratory | 2025 | |
| 2025-06-25 | scPharmaceuticals Inc. | $13,750 | Honoraria | Cash or cash equivalent | FUROSCIX Drug, Cardiology | 2025 | |
| 2025-04-03 | scPharmaceuticals Inc. | $960 | Travel and Lodging | Cash or cash equivalent | FUROSCIX Drug, Cardiology | 2025 | |
| 2025-04-01 | ZOLL Respicardia, Inc. | $3,250 | Consulting Fee | Cash or cash equivalent | remede System Device, Respiratory | 2025 | |
| 2025-03-12 | scPharmaceuticals Inc. | $13,750 | Honoraria | Cash or cash equivalent | FUROSCIX Drug, Cardiology | 2025 | |
| 2025-03-01 | ZOLL Respicardia, Inc. | $2,600 | Consulting Fee | Cash or cash equivalent | remede System Device, Respiratory | 2025 | |
| 2025-02-01 | ZOLL Respicardia, Inc. | $3,900 | Consulting Fee | Cash or cash equivalent | remede System Device, Respiratory | 2025 | |
| 2025-02-01 | ZOLL Respicardia, Inc. | $2,600 | Consulting Fee | Cash or cash equivalent | remede System Device, Respiratory | 2025 | |
| 2025-01-14 | CVRx, Inc. | $1,000 | Consulting Fee | Cash or cash equivalent | Barostim Neo System Device, Heart Failure and Hypertension | 2025 | |
| 2024-12-16 | Sensible Medical Innovations Ltd | $36,000 | Consulting Fee (4 payments) | Cash or cash equivalent | ReDS system Device, Heart failure | 2024 | |
| 2024-12-10 | scPharmaceuticals Inc. | $11,250 | Honoraria | Cash or cash equivalent | FUROSCIX Drug, Cardiology | 2024 | |
| 2024-12-01 | ZOLL Respicardia, Inc. | $3,900 | Consulting Fee | Cash or cash equivalent | remede System Device, Respiratory | 2024 | |
| 2024-10-28 | ZOLL Respicardia, Inc. | $1,300 | Consulting Fee | Cash or cash equivalent | remede System Device, Respiratory | 2024 | |
| 2024-10-01 | ZOLL Respicardia, Inc. | $5,200 | Consulting Fee | Cash or cash equivalent | remede System Device, Respiratory | 2024 | |
| 2024-09-26 | scPharmaceuticals Inc. | $11,250 | Honoraria | Cash or cash equivalent | FUROSCIX Drug, Cardiology | 2024 | |
| 2024-08-01 | ZOLL Respicardia, Inc. | $3,250 | Consulting Fee | Cash or cash equivalent | remede System Device, Respiratory | 2024 | |
| 2024-07-26 | CVRx, Inc. | $2,500 | Research payment | Cash or cash equivalent | Barostim Neo System Device, Heart Failure and Hypertension | 2024 | |
| 2024-07-01 | ZOLL Respicardia, Inc. | $15,000 | Consulting Fee | Cash or cash equivalent | remede System Device, Respiratory | 2024 | |
| 2024-06-24 | scPharmaceuticals Inc. | $11,250 | Honoraria | Cash or cash equivalent | FUROSCIX Drug, Cardiology | 2024 | |
| 2024-06-12 | Abbott Laboratories | $120 | Food and Beverage | In-kind items and services | CARDIOMEMS Device, Heart Failure | 2024 | |
| 2024-05-28 | Abbott Laboratories | $116 | Food and Beverage | In-kind items and services | CARDIOMEMS Device, Heart Failure | 2024 | |
| 2024-04-10 | CVRx, Inc. | $8,000 | Research payment | Cash or cash equivalent | Barostim Neo System Device, Heart Failure and Hypertension | 2024 | |
| 2024-03-27 | ZOLL Respicardia, Inc. | $4,550 | Consulting Fee | Cash or cash equivalent | remede System Device, Respiratory | 2024 | |
| 2024-03-22 | scPharmaceuticals Inc. | $11,250 | Honoraria | Cash or cash equivalent | FUROSCIX Drug, Cardiology | 2024 | |
| 2024-03-01 | ZOLL Respicardia, Inc. | $4,550 | Consulting Fee | Cash or cash equivalent | remede System Device, Respiratory | 2024 | |
| 2024-02-09 | Kestra Medical Technology Services, Inc. | $28 | Food and Beverage | Cash or cash equivalent | Assure WCD Device, Cardiology | 2024 | |
| 2024-02-01 | ZOLL Respicardia, Inc. | $5,000 | Consulting Fee | Cash or cash equivalent | remede System Device, Respiratory | 2024 | |
| 2024-01-25 | ZOLL Respicardia, Inc. | $9,100 | Consulting Fee | Cash or cash equivalent | remede System Device, Respiratory | 2024 | |
| 2024-01-18 | Impulse Dynamics (USA) Inc. | $1,500 | Honoraria | Cash or cash equivalent | Optimizer Device, Cardiovascular Device | 2024 | |
| 2024-01-10 | CVRx, Inc. | $8,500 | Research payment | Cash or cash equivalent | Barostim Neo System Device, Heart Failure and Hypertension | 2024 | |
| 2024-01-04 | Abbott Laboratories | $135 | Food and Beverage | In-kind items and services | CARDIOMEMS Device, Heart Failure | 2024 | |
| 2023-12-26 | scPharmaceuticals Inc. | $11,250 | Honoraria | Cash or cash equivalent | FUROSCIX Drug, Cardiology | 2023 | |
| 2023-10-25 | ZOLL Respicardia, Inc. | $2,600 | Consulting Fee | Cash or cash equivalent | remede System Device, Respiratory | 2023 | |
| 2023-10-24 | Abbott Laboratories | $550 | Consulting Fee | Cash or cash equivalent | THORATEC HEARTMATE 3 LVAS IMPLANT KIT Device, Heart Failure | 2023 | |
| 2023-10-17 | CVRx, Inc. | $15,000 | Research payment | Cash or cash equivalent | Barostim Neo System Device, Heart Failure and Hypertension | 2023 | |
| 2023-09-30 | ZOLL Respicardia, Inc. | $7,800 | Consulting Fee (3 payments) | Cash or cash equivalent | remede System Device, Respiratory | 2023 | |
| 2023-09-26 | scPharmaceuticals Inc. | $11,250 | Honoraria | Cash or cash equivalent | FUROSCIX Drug, Cardiology | 2023 | |
| 2023-09-22 | Abbott Laboratories | $81 | Food and Beverage | In-kind items and services | CARDIOMEMS Device, Heart Failure | 2023 | |
| 2023-09-13 | Impulse Dynamics (USA) Inc. | $1,500 | Honoraria | Cash or cash equivalent | OPTIMIZER Device, Cardiovascular Device | 2023 | |
| 2023-08-01 | ZOLL Respicardia, Inc. | $3,900 | Consulting Fee | Cash or cash equivalent | remede System Device, Respiratory | 2023 | |
| 2023-07-01 | ZOLL Respicardia, Inc. | $8,900 | Consulting Fee (2 payments) | Cash or cash equivalent | remede System Device, Respiratory | 2023 | |
| 2023-06-23 | scPharmaceuticals Inc. | $11,250 | Honoraria | Cash or cash equivalent | FUROSCIX Drug, Cardiology | 2023 | |
| 2023-05-01 | ZOLL Respicardia, Inc. | $3,900 | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | remede System Device, Respiratory | 2023 | |
| 2023-03-31 | ZOLL Respicardia, Inc. | $4,550 | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | remede System Device, Respiratory | 2023 | |
| 2023-03-30 | scPharmaceuticals Inc. | $11,250 | Honoraria | Cash or cash equivalent | FUROSCIX Drug, Cardiology | 2023 | |
| 2023-03-21 | Impulse Dynamics (USA) Inc. | $2,500 | Honoraria | Cash or cash equivalent | OPTIMIZER Device, Cardiovascular Device | 2023 | |
| 2023-03-01 | ZOLL Respicardia, Inc. | $13,450 | Compensation for serving as faculty or as a speaker for a medical education program (3 payments) | Cash or cash equivalent | remede System Device, Respiratory | 2023 | |
| 2023-02-19 | CVRx, Inc. | $105 | Research payment | Cash or cash equivalent | Barostim Neo System Device, Heart Failure and Hypertension | 2023 | |
| 2023-02-18 | CVRx, Inc. | $105 | Research payment | Cash or cash equivalent | Barostim Neo System Device, Heart Failure and Hypertension | 2023 | |
| 2023-02-17 | CVRx, Inc. | $274 | Research payment | Cash or cash equivalent | Barostim Neo System Device, Heart Failure and Hypertension | 2023 | |
| 2023-02-01 | Sensible Medical Innovations Ltd | $33,000 | Consulting Fee (3 payments) | Cash or cash equivalent | ReDS system Device, Heart failure | 2023 | |
| 2023-01-24 | CVRx, Inc. | $598 | Research payment | Cash or cash equivalent | Barostim Neo System Device, Heart Failure and Hypertension | 2023 | |
| 2022-11-07 | Sensible Medical Innovations Ltd | $54,000 | Consulting Fee (3 payments) | Cash or cash equivalent | ReDS system Device, Heart failure | 2022 | |
| 2022-10-13 | ZOLL Respicardia, Inc. | $18,200 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v (4 payments) | Cash or cash equivalent | remede System Device, Respiratory | 2022 | |
| 2022-09-09 | Abbott Laboratories | $61 | Food and Beverage | In-kind items and services | CARDIOMEMS Device, Heart Failure | 2022 | |
| 2022-06-13 | Impulse Dynamics (USA) Inc. | $2,000 | Honoraria | Cash or cash equivalent | Optimizer Device, Cardiovascular | 2022 | |
| 2022-05-19 | Impulse Dynamics (USA) Inc. | $2,500 | Honoraria | Cash or cash equivalent | Optimizer Device, Cardiovascular | 2022 | |
| 2022-04-27 | Edwards Lifesciences Corporation | $1,500 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | In-kind items and services | 2022 | ||
| 2022-02-01 | ZOLL Respicardia, Inc. | $31,650 | Consulting Fee (6 payments) | Cash or cash equivalent | remede System Device, Respiratory | 2022 | |
| 2022-01-26 | Edwards Lifesciences Corporation | $76 | Food and Beverage | In-kind items and services | 2022 | ||
| 2021-10-28 | Impulse Dynamics (USA) Inc. | $2,000 | Consulting Fee | Cash or cash equivalent | Optimizer Smart System Device, Cardiovascular Device | 2021 | |
| 2021-10-28 | Impulse Dynamics (USA) Inc. | $2,000 | Consulting Fee | Cash or cash equivalent | Optimizer Smart System Device, Cardiovascular Device | 2021 | |
| 2021-10-08 | Boehringer Ingelheim International GmbH | $439 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | In-kind items and services | JARDIANCE Drug, DIABETES | 2021 | |
| 2021-08-31 | Impulse Dynamics (USA) Inc. | $2,000 | Consulting Fee | Cash or cash equivalent | Optimizer Smart System Device, Cardiovascular Device | 2021 | |
| 2021-08-31 | Impulse Dynamics (USA) Inc. | $2,000 | Consulting Fee | Cash or cash equivalent | Optimizer Smart System Device, Cardiovascular Device | 2021 | |
| 2021-08-31 | Impulse Dynamics (USA) Inc. | $2,000 | Consulting Fee | Cash or cash equivalent | Optimizer Smart System Device, Cardiovascular Device | 2021 | |
| 2021-08-31 | Impulse Dynamics (USA) Inc. | $2,000 | Consulting Fee | Cash or cash equivalent | Optimizer Smart System Device, Cardiovascular Device | 2021 | |
| 2021-01-01 | ZOLL Respicardia, Inc. | $60,000 | Consulting Fee (12 payments) | Cash or cash equivalent | remede System Device, Respiratory | 2021 | |
| 2020-12-08 | Boehringer Ingelheim International GmbH | $688 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | In-kind items and services | JARDIANCE Drug, DIABETES | 2020 | |
| 2020-12-08 | Boehringer Ingelheim International GmbH | $507 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | In-kind items and services | JARDIANCE Drug, DIABETES | 2020 | |
| 2020-12-08 | Boehringer Ingelheim International GmbH | $507 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | In-kind items and services | JARDIANCE Drug, DIABETES | 2020 | |
| 2020-12-08 | Boehringer Ingelheim International GmbH | $238 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | In-kind items and services | JARDIANCE Drug, DIABETES | 2020 | |
| 2020-12-08 | Boehringer Ingelheim International GmbH | $217 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | In-kind items and services | JARDIANCE Drug, DIABETES | 2020 | |
| 2020-12-08 | Boehringer Ingelheim International GmbH | $170 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | In-kind items and services | JARDIANCE Drug, DIABETES | 2020 | |
| 2020-07-30 | Impulse Dynamics (USA) Inc. | $6,000 | Consulting Fee (3 payments) | Cash or cash equivalent | OPTIMIZER SMART SYSTEM Device, CARDIOVASCULAR DEVICE | 2020 | |
| 2020-02-05 | Boehringer Ingelheim France S.A.S. | $20,013 | Consulting Fee | Cash or cash equivalent | 2020 | ||
| 2020-01-16 | ZOLL Respicardia, Inc. | $238 | Travel and Lodging | Cash or cash equivalent | remede System Device, Respiratory | 2020 | |
| 2020-01-15 | Sensible Medical Innovations Ltd | $18,000 | Consulting Fee | Cash or cash equivalent | ReDS system Device, Heart failure | 2020 | |
| 2020-01-01 | ZOLL Respicardia, Inc. | $55,000 | Consulting Fee (11 payments) | Cash or cash equivalent | remede System Device, Respiratory | 2020 | |
| 2019-11-17 | Novartis Pharmaceuticals Corporation | $3,960 | Consulting Fee | Cash or cash equivalent | ENTRESTO Drug, CARDIOVASCULAR | 2019 | |
| 2019-09-14 | CVRx, Inc. | $176 | Food and Beverage | In-kind items and services | Barostim Neo System Device, Heart Failure and Hypertension | 2019 | |
| 2019-06-30 | Boehringer Ingelheim International GmbH | $1,548 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | In-kind items and services | JARDIANCE Drug, DIABETES | 2019 | |
| 2019-05-06 | CVRx, Inc. | $372 | Travel and Lodging | Cash or cash equivalent | Barostim Neo System Device, Heart Failure and Hypertension | 2019 | |
| 2019-04-19 | CVRx, Inc. | $57 | Food and Beverage | In-kind items and services | Barostim Neo System Device, Heart Failure and Hypertension | 2019 | |
| 2019-04-12 | ZOLL Respicardia, Inc. | $625 | Travel and Lodging | Cash or cash equivalent | remede System Device, Respiratory | 2019 | |
| 2019-02-26 | Abbott Laboratories | $1,787 | Research payment | Cash or cash equivalent | Tendyne Mitral Valve System Device, Vascular | CEASE-MR | 2019 |
| 2019-02-11 | ZOLL Respicardia, Inc. | $1,109 | Travel and Lodging | Cash or cash equivalent | remede System Device, Respiratory | 2019 | |
| 2019-02-01 | ZOLL Respicardia, Inc. | $60,000 | Consulting Fee (12 payments) | Cash or cash equivalent | remede System Device, Respiratory | 2019 | |
| 2019-01-21 | Abbott Laboratories | $3,000 | Consulting Fee | Cash or cash equivalent | Mitra Clip system Device, Vascular | 2019 | |
| 2019-01-15 | Abbott Laboratories | $3,500 | Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing | Cash or cash equivalent | Mitra Clip system Device, Vascular | 2019 | |
| 2019-01-10 | CVRx, Inc. | $4,268 | Consulting Fee | Cash or cash equivalent | Barostim Neo System Device, Heart Failure and Hypertension | 2019 | |
| 2019-01-01 | Sensible Medical Innovations Ltd | $72,000 | Consulting Fee (4 payments) | Cash or cash equivalent | ReDS system Device, Heart failure | 2019 | |
| scPharmaceuticals Inc. | $0 interest valued $82,856 | Ownership or investment interest | Physician Covered Recipient | Board Member ownership pay out with company aquisition. | 2025 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Powell, OH, county Delaware County, OH, state Ohio; placed by its city name.
| Measure | Place (city or town) Powell, OH | County Delaware County, OH | State Ohio |
|---|---|---|---|
| Population B01003 | 14,451 | 226,834 | 11,810,293 |
| Population, 2020 census P1 | 14,163 | 214,124 | 11,799,448 |
| Median age B01002 | 42.8 | 40.1 | 39.7 |
| Under 18 B01001 | 27.6% | 24.8% | 22.0% |
| 65 and over B01001 | 17.6% | 15.1% | 18.3% |
| Households B11001 | 5,163 | 82,287 | 4,863,191 |
| Foreign born B05002 | 14.7% | 9.7% | 5.2% |
| Median household income B19013 | $195,495 | $133,540 | $71,389 |
| Median family income B19113 | $214,143 | $157,087 | $92,749 |
| Per capita income B19301 | $85,284 | $61,395 | $40,552 |
| Poverty rate B17001 | 1.1% | 4.7% | 13.3% |
| Unemployment rate B23025 | 2.0% | 3.0% | 4.8% |
| Civilian labor force B23025 | 7,241 | 123,902 | 5,994,779 |
| Mean commute (minutes) B08013 | 24.3 | 25.4 | 23.4 |
| Bachelor's degree or higher B15003 | 78.1% | 59.4% | 31.5% |
| Housing units B25001 | 5,669 | 86,269 | 5,292,391 |
| Owner-occupied B25003 | 88.0% | 78.5% | 67.2% |
| Renters B25003 | 12.0% | 21.5% | 32.8% |
| Median home value B25077 | $561,500 | $445,500 | $214,800 |
| Median gross rent B25064 | $2,194 | $1,492 | $1,034 |
| White, not Hispanic B03002 | 77.0% | 79.2% | 75.8% |
| Black B03002 | 1.2% | 4.3% | 12.0% |
| Hispanic or Latino B03002 | 2.0% | 3.5% | 4.8% |
| Asian B03002 | 14.7% | 8.6% | 2.5% |
| American Indian and Alaska Native B03002 | 0.1% | 0.0% | 0.1% |
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Powell, OH.
Comments